Cargando…
Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275>
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186588/ https://www.ncbi.nlm.nih.gov/pubmed/32268279 http://dx.doi.org/10.1016/j.ebiom.2020.102741 |
| _version_ | 1783526981688623104 |
|---|---|
| author | Gan, Yu Li, Yinan Long, Zhi Lee, Ahn R. Xie, Ning Lovnicki, Jessica M. Tang, Yuxin Chen, Xiang Huang, Jiaoti Dong, Xuesen |
| author_facet | Gan, Yu Li, Yinan Long, Zhi Lee, Ahn R. Xie, Ning Lovnicki, Jessica M. Tang, Yuxin Chen, Xiang Huang, Jiaoti Dong, Xuesen |
| author_sort | Gan, Yu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7186588 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71865882020-05-04 Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> Gan, Yu Li, Yinan Long, Zhi Lee, Ahn R. Xie, Ning Lovnicki, Jessica M. Tang, Yuxin Chen, Xiang Huang, Jiaoti Dong, Xuesen EBioMedicine Corrigendum Elsevier 2020-04-27 /pmc/articles/PMC7186588/ /pubmed/32268279 http://dx.doi.org/10.1016/j.ebiom.2020.102741 Text en © 2020 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Corrigendum Gan, Yu Li, Yinan Long, Zhi Lee, Ahn R. Xie, Ning Lovnicki, Jessica M. Tang, Yuxin Chen, Xiang Huang, Jiaoti Dong, Xuesen Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title | Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title_full | Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title_fullStr | Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title_full_unstemmed | Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title_short | Corrigendum to ‘Roles of alternative RNA splicing of the Bif-1 gene by SRRM4 during the development of treatment-induced neuroendocrine prostate cancer’. [EBioMedicine 31 (2018) 267–275> |
| title_sort | corrigendum to ‘roles of alternative rna splicing of the bif-1 gene by srrm4 during the development of treatment-induced neuroendocrine prostate cancer’. [ebiomedicine 31 (2018) 267–275> |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186588/ https://www.ncbi.nlm.nih.gov/pubmed/32268279 http://dx.doi.org/10.1016/j.ebiom.2020.102741 |
| work_keys_str_mv | AT ganyu corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT liyinan corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT longzhi corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT leeahnr corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT xiening corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT lovnickijessicam corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT tangyuxin corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT chenxiang corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT huangjiaoti corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 AT dongxuesen corrigendumtorolesofalternativernasplicingofthebif1genebysrrm4duringthedevelopmentoftreatmentinducedneuroendocrineprostatecancerebiomedicine312018267275 |